About Ergomed

Ergomed Group delivers specialized clinical research, pharmacovigilance and regulatory compliance services to pharmaceutical and biotechnology companies. The organization operates through three divisions: Ergomed Clinical Research handles oncology, rare disease and complex trials; PrimeVigilance provides drug safety and medical information services; and ADAMAS Consulting offers GxP audits across the development lifecycle. Operating across 100 countries, Ergomed supports over 500 clients from major pharmaceutical companies to emerging biotech firms. The group combines therapeutic expertise with global operational capabilities to address complex clinical development challenges and advance new medicines to patients.